This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Avian Leukosis Virus Antigen
Product Overview
BioVenic's Recombinant Avian Leukosis Virus Antigen is a recombinant antigen produced by E.coli. This antigen has undergone a rigorous purification process. It can be used for ELISA plate coating or for the preparation of enzyme conjugates.
Specifications
Target Information
Avian Leukosis Virus (ALV) is an enveloped, single-stranded RNA retrovirus that induces neoplastic diseases, primarily lymphoid leukosis, and immunosuppression in poultry. It is classified into subgroups (A to J) based on envelope interference and host range. Key targets for diagnostics and vaccine research include the group-specific capsid antigen p27, used for broad virus detection, and the highly variable gp85 envelope glycoprotein, which determines subgroup specificity, drives host cell receptor binding, and serves as the primary target for neutralizing antibodies.
Shipping and Storage
This product is shipped with gel ice bags. Store at 0-4°C for no more than 2 weeks, or -20°C or below for long-term storage.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.